Intended for healthcare professionals

  1. Research
  2. Randomised controlled...
  3. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
Papers

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

BMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7076.253 (Published 25 January 1997) Cite this as: BMJ 1997;314:253

Related articles

See more

Cited by...

  • Update on the Use of Intravenous Immunoglobulin in Pregnancy
  • EULAR recommendations for the management of antiphospholipid syndrome in adults
  • Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults
  • High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant
  • Antiangiogenic effects of decorin restored by unfractionated, low molecular weight, and nonanticoagulant heparins
  • Antiphospholipid Syndrome: Role of Vascular Endothelial Cells and Implications for Risk Stratification and Targeted Therapeutics
  • The antiphospholipid syndrome: still an enigma
  • Anticoagulation in pregnancy complications
  • Preventing pregnancy loss
  • Treatment of 139 Pregnancies in Antiphospholipid-positive Women Not Fulfilling Criteria for Antiphospholipid Syndrome: A Retrospective Study
  • Is heparin a placental anticoagulant in high-risk pregnancies?
  • Consultative Hematology: The Pregnant Patient Pregnancy Loss
  • SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage
  • Clark, et al, reply
  • Low Molecular Weight Heparin and Aspirin for Recurrent Pregnancy Loss: Results from the HepASA Trial
  • How I treat the antiphospholipid syndrome
  • Low Molecular Weight Heparin and Aspirin for Recurrent Pregnancy Loss: Results from the Randomized, Controlled HepASA Trial
  • How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based review
  • Management of Hereditary Hypercoagulable Disorders
  • Investigation of recurrent miscarriages
  • Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy
  • Clinical management of thrombophilia-related placental vascular complications
  • Antiphospholipid syndrome: an overview
  • Pregnancy in systemic lupus erythematosus
  • How to treat women with antiphospholipid antibodies in pregnancy?
  • Thrombophilia in pregnancy
  • Thrombophilia testing: what do we think the tests mean and what should we do with the results?
  • Testing for and Clinical Significance of Anticardiolipin Antibodies
  • Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies
  • Low-dose aspirin plus heparin led to a higher rate of live births in women with recurrent miscarriages and phospholipid antibodies
  • Systemic lupus erythematosus complicated by antiphospholipid antibody syndrome
  • ASPIRIN PLUS HEPARIN FOR MISCARRIAGE DUE TO PHOSPHOLIPID ANTIBODIES
  • Aspirin Plus Heparin for Miscarriage Due to Phospholipid Antibodies
  • Antiphospholipid (Hughes') syndrome
Back to top